Results 291 to 300 of about 490,902 (326)

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong   +2 more
exaly  

Targeted drug delivery strategies for precision medicines

Nature Reviews Materials, 2021
Mandana T Manzari   +2 more
exaly  

Phase I study cohort evaluating an optimized administration schedule of SAR3419, an anti-CD19 DM4-loaded antibody drug conjugate (ADC), in patients (pts) with CD19 positive relapsed/refractory b-cell non-Hodgkin’s lymphoma (NCT00796731).

open access: closed, 2012
Bertrand Coiffier   +11 more
openalex   +1 more source

Drug Enforcement Administration Drug Scheduling

open access: closed, 2020
Michael Lopez, Prasanna Tadi
openalex  

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

Home - About - Disclaimer - Privacy